Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, today announced it has...
Kala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, announced...
